Ashleigh Palmer - 30 Nov 2021 Form 4 Insider Report for Provention Bio, Inc.

Role
Director and CEO, Director
Signature
/s/ Heidy King-Jones, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
30 Nov 2021
Net transactions value
+$24,990
Form type
4
Filing time
01 Dec 2021, 20:21:07 UTC
Previous filing
14 May 2021
Next filing
20 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVB Common Stock Purchase $24,990 +3,750 +0.15% $6.66 2,570,050 30 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.566 to $6.70, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Remarks:

Exhibit 24.1 - Power of Attorney